Fri, Nov 28, 2014, 11:18 PM EST - U.S. Markets closed early today

Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • freddyaophelps freddyaophelps Jul 30, 2014 10:48 AM Flag

    A few facts about ACTC.

    Patient confirmed to have sight restored from 20/400 to 20/40.
    Advanced Cell Technology has told investors that trial data has been presented for peer review.
    A new and respected CEO has been hired to transition the company forward.
    Past litigation and legacy issues have been settled.
    Mr. Wotton was named as the 2014 Ernst and Young "Entrepreneur of the Year"
    Robert Lanza, MD, has been selected for the 2014 TIME 100 annual list of the hundred most influential people in the world.
    A recent statement found in In Vivo magazine quotes Dr. Matthew Vincent, Director of Corporate Development, as stating, "we have treated about thirty patients in this way... in over half of them we have seen improvement in vision, modest for some and spectacular for others."
    ACTC has made a point to disclose on several occasions that no serious side effects or patient complications have occurred in trial study patients, evidenced by the approval to continue the trials from the Data Safety Monitoring Board.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think it is becoming obvious that the 20/400 to 20/40 was the exception, still fanastic but not the big deal for ACT that we would like. I am becoming more resigned to the fact this investment is a bust and while some form of the company may very well survive it does not appear it will do much for todays shareholders. i thought we might expect .28 next year or $28.00 post split but now with the latest dilution that would be about .17 or $17.00. A nice return to be sure for folks coming on board in the next few months but for folks holding this the last several years not so much. Very depressing to say the least.

    • Re: A few facts about ACTC

      ACTCs new accounting firm BDO USA, LLP.

      Form 8-K 9/23/14
      Item 4.01 Changes in Registrant’s Certifying Accountant.
      (a), (b) On September 17, 2014, the Audit Committee (the “Audit Committee”) of the Board of Directors of Advanced Cell Technology, Inc. (the “Company”) dismissed SingerLewak LLP (“SingerLewak”), and engaged BDO USA, LLP (“BDO”), as the Company’s independent registered public accounting firm effective immediately.

      BDO USA, LLP formerly know as BDO Seidman, LLP.

      BDO were involved in :

      Tax fraud conspiracy
      Option backdating scandal
      Washington DC tax scandal
      NY Law School & Madoff scandal
      Miami bank fraud
      etc.

      : )

    • Re: A few facts about ACTC.

      The National Law Review
      SEC Targets Corporate Insiders for Failing to Promptly Disclose Stock Transactions
      posted on: Thursday, September 18, 2014

      (excerpt)

      In a separate case announced by the SEC on the same date, a company was charged with violations of the reporting requirements under the Exchange Act and the antifraud provisions in the proxy rules under the Exchange Act as well as those under the Securities Act of 1933, as amended (Securities Act).[3] The SEC charged the company, Advanced Cell Technology Inc., with making false and misleading statements regarding its CEO’s noncompliance with Section 16(a) reporting requirements. In particular, the company reported four late Form 4 filings by the CEO and other late filings by certain of its directors but made no disclosure about the CEO’s failure to report trading in the company’s common stock on 14 other trading days. The SEC deemed the company’s misstatements to be false and misleading, stating that “[t]here is a substantial likelihood that [the CEO’s] trades would have significant importance to the reasonable Advanced Cell investor given, among other things, his position as CEO, the frequency with which he was selling Advanced Cell stock, and his failures to comply with reporting requirements.”

      : )

      • 1 Reply to beareclawe
      • Re: Re: A few facts about ACTC.

        UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION
        SECURITIES ACT OF 1933 Release No. 9644 / September 10, 2014
        SECURITIES EXCHANGE ACT OF 1934 Release No. 73066 / September 10, 2014
        ADMINISTRATIVE PROCEEDING File No. 3-16095
        In the Matter of ADVANCED CELL TECHNOLOGY, INC. Respondent.
        ORDER INSTITUTING CEASE AND DESIST PROCEEDINGS PURSUANT TO 8A OF THE SECURITIES ACT OF 1933 AND SECTION 21C OF THE SECURITIES EXCHANGE ACT OF 1934, MAKING FINDINGS, AND IMPOSING A CEASE AND DESIST ORDER

        (excerpt)

        3. On May 31, 2012, the Commission charged Advanced Cell with violating Sections 5(a) and 5(c) of the Securities Act and Section 13(a) of the Exchange Act and Rule 13a thereunder. On December 30, 2013, the United States District Court for the Middle District of Florida approved a settlement between the Commission and Advanced Cell pursuant to which Advanced Cell was permanently enjoined from future violations of Sections 5(a) and 5(c) of the Securities Act and Section 13(a) of the Exchange Act and Rule 13a thereunder and was ordered to pay $3,500,000 in disgorgement and $586,619 in prejudgment interest. Advanced Cell is currently paying those amounts through a payment plan, with the final payment of $681,104.16 due on April 15, 2015.

        : )

    • This deserves to be at the top.

    • Improvement in over half the patients does not seem very encouraging.

    • Here's a fact, ACTC is 6 - 7 cent stock, and it's been that way for a long time, which makes all your facts null & void, just like whats between your ears.

    • We'll said,very compelling information, what is their not to like about this stock going forward!

      Sentiment: Strong Buy

    • Fred, good post.. In my opinion, and my prediction, ACTC will be breaking the ten cent ceiling by the end of August, with trial data results formally out. Once CNN gets the scoop and an interview with both Dr. Wotton and Dr. Lanza.. ( i.e. concerning the positive results), there should be no looking back. Good luck. Have a great day.

      Sentiment: Strong Buy

    • Freddy,

      Don't forget the most important one:

      1. ACTC posted Mr. Wotton's picture on their web page....

      Now we should rocket TOOOOOOOOOOOOO DAAAAAAAAAAAAAAAA MOOOOOOOOONNNNNNNN any day now.....

      JSN

      Sentiment: Strong Buy

    • Fred-
      Good recap but the reality is most informed shareholders have logged that information already and its reflected in the share price as well as outstanding stock.

      The uptick will come as "revenue" get closer. The items which firm up revenue are the following:

      1) ITLD in recognized journal
      2) Phase II
      3) Animal results at Tufts
      4) Other program launch
      5) Proven high volume manufacturing for SMD/AMD.

      That's how I see it. Please add anything I've left out which cinches down the revenue stream timeline.

    • View More Messages
 
ACTC
6.97+0.17(+2.50%)Nov 13 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.